ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,842, issued on May 19, was assigned to VOYAGER THERAPEUTICS INC. (Lexington, Mass.).

"Redirection of tropism of AAV capsids" was invented by Mathieu E. Nonnenmacher (Boston), Jinzhao Hou (Lexington, Mass.), Wei Wang (Lexington, Mass.), Matthew Child (Ashland, Mass.) and Shaoyong Li (Hopkinton, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to compositions, methods, and processes for the preparation, use, and/or formulation of adeno-associated virus capsid proteins, wherein the capsid proteins comprise targeting peptide inserts tor enhanced tropism to a target tissue."

The patent was filed on March 31, 2021, under Applica...